Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study Meeting Abstract


Authors: Hyman, D. M.; Kaley, T. J.; Hollebecque, A.; Subbiah, V.; Ahnert, J. R.; Lockhart, A. C.; Keedy, V. L.; Hofheinz, R.; Lobbedez, F. J.; Blay, J. Y.; Chau, I.; Puzanov, I.; Raje, N.; Wolf, J.; Makrutzki, M.; Riehl, T.; Pitcher, B.; Baselga, J.
Abstract Title: Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 87s
Language: English
ACCESSION: WOS:000411895703174
DOI: 10.1200/JCO.2017.35.15_suppl.2004
PROVIDER: wos
Notes: Meeting Abstract: 2004 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Thomas Kaley
    154 Kaley
  2. David Hyman
    354 Hyman
  3. Jose T Baselga
    484 Baselga